Читать книгу Metabolic Syndrome Consequent to Endocrine Disorders - Группа авторов - Страница 26

We should realize the cumulative effect of dysfunction of multiple pituitary hormonal axes on adverse metabolic and cardiovascular disease profile. We should also understand the challenges in pituitary replacement therapy and interaction between hormones used for replacement in hypopituitarism (e.g. excessive HC coupled with suboptimal treatment of other pituitary hormone deficiencies) and how this may contribute to the adverse cardiometabolic milieu. Pro-active treatment of all associated cardiometabolic comorbidities and risk factors is also advocated as well as the regular risk assessment and re-evaluation during the long-term follow-up.